Role of epidermal growth factor receptor signaling in a Pt(II)-resistant human breast cancer cell line.
Breast cancer
EGFR
ERK1/2
PI3K/Akt
PKC-δ
Src
Journal
Biochemical pharmacology
ISSN: 1873-2968
Titre abrégé: Biochem Pharmacol
Pays: England
ID NLM: 0101032
Informations de publication
Date de publication:
10 2021
10 2021
Historique:
received:
27
05
2021
revised:
21
07
2021
accepted:
22
07
2021
pubmed:
30
7
2021
medline:
17
11
2021
entrez:
29
7
2021
Statut:
ppublish
Résumé
Platinum complexes are currently used for breast cancer therapy, but, as with other drug classes, a series of intrinsic and acquired resistance mechanisms hinder their efficacy. To better understand the mechanisms underlying platinum complexes resistance in breast cancer, we generated a [Pt(O,O'-acac)(γ-acac)(DMS)]-resistant MCF-7, denoted as [Pt(acac)
Identifiants
pubmed: 34324869
pii: S0006-2952(21)00315-4
doi: 10.1016/j.bcp.2021.114702
pii:
doi:
Substances chimiques
Platinum Compounds
0
EGFR protein, human
EC 2.7.10.1
ErbB Receptors
EC 2.7.10.1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
114702Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.